About China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP)
China Nuokang Bio-Pharmaceutical Inc. is a biopharmaceutical company focused on research, development, manufacture, marketing and sales of hospital-based medical products. As of December 31, 2010, it sold a portfolio of 15 products, including four principal products: Baquting, its bleeding control product; Kaitong, its lipid emulsion alprostadil product for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis; Aiduo, its cardiovascular stress imaging agent, and Aiwen, its anti-arrhythmic agent. Its product pipeline includes three product candidates under development for bleeding control and hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. In February 2013, it announced the completion of the merger with Kingbird Mergerco. Inc., a wholly owned subsidiary of Kingbird Investment Inc. As a result of the merger the Company became a wholly owned subsidiary of Kingbird Investment Inc.
Industry, Sector and Symbol
Industry Bio Therapeutic Drugs
Trailing P/E Ratio-19.7857142857143
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Frequently Asked Questions
What is China Nuokang Bio-Pharmaceutical's stock symbol?
China Nuokang Bio-Pharmaceutical trades on the NASDAQ under the ticker symbol "NKBP."
Who are some of China Nuokang Bio-Pharmaceutical's key competitors?
Some companies that are related to China Nuokang Bio-Pharmaceutical include Tocagen (TOCA), Vital Therapies (VTL), Minerva Neurosciences (NERV), Selecta Biosciences (SELB), Vascular Biogenics (VBLT), ImmuPharma (IMM), Ampio Pharmaceuticals (AMPE), Axovant Sciences (AXON), Endocyte (ECYT), Ovid Therapeutics (OVID), Athersys (ATHX), Otonomy (OTIC), XBiotech (XBIT), DURECT (DRRX), Recro Pharma (REPH), Summit Therapeutics (SMMT), Clearside Biomedical (CLSD) and Spring Bank Pharmaceuticals (SBPH).
How do I buy China Nuokang Bio-Pharmaceutical stock?
Shares of China Nuokang Bio-Pharmaceutical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is China Nuokang Bio-Pharmaceutical's stock price today?
One share of China Nuokang Bio-Pharmaceutical stock can currently be purchased for approximately $5.54.
How big of a company is China Nuokang Bio-Pharmaceutical?
China Nuokang Bio-Pharmaceutical has a market capitalization of $108.95 million.
How can I contact China Nuokang Bio-Pharmaceutical?
China Nuokang Bio-Pharmaceutical's mailing address is No. 18-1 East Nanping Road Hunnan Natnl New & High-tch Dvlpmnt Zone, SHENYANG, LIA 110171, China. The biopharmaceutical company can be reached via phone at +86-24-24696033.
MarketBeat Community Rating for China Nuokang Bio-Pharmaceutical (NKBP)MarketBeat's community ratings are surveys of what our community members think about China Nuokang Bio-Pharmaceutical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Earnings History and Estimates Chart
China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for China Nuokang Bio-Pharmaceutical (NASDAQ NKBP)
No insider trades for this company have been tracked by MarketBeat.com
China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) News Headlines
No headlines for this company have been tracked by MarketBeat.com
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Income Statement, Balance Sheet and Cash Flow Statement
China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Stock Chart for Saturday, February, 24, 2018